Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1DOUGLAS PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEnd-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

Patent Expiration Date : 2028-05-01

CLOZAPINE

US Patent Number : 8057811

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203479

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-05-01

Douglas CDMO